Reference SummarySinn E, Cell 1987 May 22;49(4):465-75
Title |
Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. | ||||||||
Authors |
Sinn E; Muller W; Pattengale P; Tepler I; Wallace R; Leder P | ||||||||
Journal |
Cell | ||||||||
Volume |
49 | ||||||||
Issue |
4 | ||||||||
Year |
1987 | ||||||||
Pages |
465-75 | ||||||||
Abstract |
We have derived and mated separate strains of transgenic mice that carry either the v-Ha-ras or the c-myc gene driven by the mouse mammary tumor virus (MMTV) promoter/enhancer. Mice carrying the MMTV/v-Ha-ras transgene manifest two distinct disturbances of cell growth. The first, a benign hyperplasia of the Harderian lacrimal gland, is diffuse, involves the entire gland, and likely requires only the abnormal action of the v-Ha-ras gene. The second involves the focal development of malignancies of mammary, salivary, and lymphoid tissue and likely requires additional somatic events. When the MMTV/v-Ha-ras and MMTV/c-myc strains are crossed to yield hybrid mice, their joint action results in a dramatic and synergistic acceleration of tumor formation. Since these tumors arise stochastically and are apparently monoclonal in origin, additional somatic events appear necessary for their full malignant progression, even in the presence of activated v-Ha-ras and c-myc transgenes. | ||||||||
Links |
J:46454 – MGI References 3032456 – National Library of Medicine/PubMed |
||||||||
Strain Notes
|
|||||||||
| Strain | Model Name | Treatment Agent(s) | Organ Affected | Frequency | Model Details |
|---|---|---|---|---|---|
| CD-1;B6-Tg(MMTV-vHaras)SH1Led | Eye - Harderian gland hyperplasia | Eye - Harderian gland |
observed - 20 |
||
| CD-1;B6-Tg(MMTV-Myc)141-3Led Tg(MMTV-vHaras)SH1Led | Eye - Harderian gland hyperplasia | Eye - Harderian gland |
observed |
||
| CD-1;B6-Tg(MMTV-vHaras)SQ1Led | Eye - Harderian gland hyperplasia | Eye - Harderian gland |
14 |
||
| CD-1;B6-Tg(MMTV-vHaras)SH1Led | Leukocyte - Lymphoblast lymphoma - lymphoblastic | Leukocyte - Lymphoblast |
0 - observed |
||
| CD-1;B6-Tg(MMTV-Myc)141-3Led Tg(MMTV-vHaras)SH1Led | Leukocyte - Lymphocyte - B-lymphocyte - Follicular center cell lymphoma | Leukocyte - Lymphocyte - B-lymphocyte - Follicular center cell |
9.5 |
||
| CD-1;B6-Tg(MMTV-Myc)141-3Led Tg(MMTV-vHaras)SH1Led | Leukocyte - Lymphocyte - B-lymphocyte lymphoma - immunoblastic | Leukocyte - Lymphocyte - B-lymphocyte |
observed - 29 |
||
| CD-1;B6-Tg(MMTV-Myc)141-3Led | Leukocyte lymphoma | Leukocyte |
0 |
||
| CD-1;B6-Tg(MMTV-Myc)141-3Led | Mammary gland adenocarcinoma | Mammary gland |
0 - 50 |
||
| CD-1;B6-Tg(MMTV-Myc)141-3Led Tg(MMTV-vHaras)SH1Led | Mammary gland adenocarcinoma | Mammary gland |
high - 86 |
||
| CD-1;B6-Tg(MMTV-vHaras)SH1Led | Mammary gland adenocarcinoma | Mammary gland |
observed - 77 |
||
| CD-1;B6-Tg(MMTV-vHaras)SH1Led | Salivary gland - Parotid adenocarcinoma | Salivary gland - Parotid |
observed - 17 |
||
| CD-1;B6-Tg(MMTV-Myc)141-3Led Tg(MMTV-vHaras)SH1Led | Salivary gland - Parotid adenocarcinoma | Salivary gland - Parotid |
19 |
||
| CD-1;B6-Tg(MMTV-Myc)141-3Led Tg(MMTV-vHaras)SH1Led | Salivary gland adenocarcinoma | Salivary gland |
observed |
||
| CD-1;B6-Tg(MMTV-Myc)141-3Led | Salivary gland tumor | Salivary gland |
0 |
||
| CD-1;B6-Tg(MMTV-Myc)141-3Led Tg(MMTV-vHaras)SH1Led | Seminal vesicle tumor | Seminal vesicle |
observed |
||
| CD-1;B6 | (Unspecified organ) tumor | (Unspecified organ) |
0 |
||
| CD-1;B6-Tg(MMTV-Myc)141-3Led | (Unspecified organ) tumor | (Unspecified organ) |
0 |